Arbutus to Present at Jefferies London Healthcare Conference
November 14, 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
Arbutus to Present at Jefferies Healthcare Conference
May 31, 2023 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., May 31, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
Synlogic to Present at the Jefferies Global Healthcare Conference
May 23, 2023 06:50 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that Aoife Brennan, M.B....
Travere Therapeutics to Present at the 2022 Jefferies Healthcare Conference
June 02, 2022 16:30 ET
|
Travere Therapeutics, Inc.
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will present at the 2022 Jefferies Healthcare Conference on Thursday,...
Arbor Biotechnologies to Present at the Evercore ISI GenomeRx Emerging Therapeutics Conference and the Jefferies Virtual Healthcare Conference
June 02, 2021 08:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company discovering and developing the next generation of genetic medicines, announced today...
Morphic to Present at the Jefferies Virtual Healthcare Conference
May 27, 2020 08:00 ET
|
Morphic Therapeutic
WALTHAM, Mass., May 27, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment...
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
May 29, 2019 16:01 ET
|
Kiniksa Pharmaceuticals, Ltd.
HAMILTON, Bermuda, May 29, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at the following investor conferences in June: Jefferies 2019...
XOMA to Present at the Jefferies Global Healthcare Conference
June 02, 2016 13:48 ET
|
XOMA Corporation
BERKELEY, Calif., June 02, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today that John Varian, the...